lidocaine has been researched along with Lichen Sclerosis in 2 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Excerpt | Relevance | Reference |
---|---|---|
"Recurrences were more frequent on HPS for moderate-stage LS (p = ." | 1.38 | Lichen sclerosus: a 5-year follow-up after topical, subdermal, or combined therapy. ( Galloway, ML; Swenson, KM; Ventolini, G, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
van der Avoort, IA | 1 |
Tiemes, DE | 1 |
van Rossum, MM | 1 |
van der Vleuten, CJ | 1 |
Massuger, LF | 1 |
de Hullu, JA | 1 |
Ventolini, G | 1 |
Swenson, KM | 1 |
Galloway, ML | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Triamcinolone Acetonide Injections Compared With Micro Injections (MMP Technique) of Triamcinolone Acetonide for the Treatment of Female Genital Lichen Sclerosus and Atrophic[NCT06079645] | Phase 4 | 20 participants (Anticipated) | Interventional | 2023-10-20 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for lidocaine and Lichen Sclerosis
Article | Year |
---|---|
Lichen sclerosus: treatment and follow-up at the departments of gynaecology and dermatology.
Topics: Academic Medical Centers; Administration, Topical; Adrenal Cortex Hormones; Anesthetics, Local; Anti | 2010 |
Lichen sclerosus: a 5-year follow-up after topical, subdermal, or combined therapy.
Topics: Administration, Topical; Adult; Anesthetics, Local; Cohort Studies; Databases, Factual; Dose-Respons | 2012 |